Search Result "poor performance status (PS)"
A Review of the Treatment Strategies for Small Cell Lung Carcinoma Patients with a Poor Performance Status
Journal: Current Respiratory Medicine Reviews
Volume: 2 Issue: 1 Year: 2006 Page: 59-66
Author(s): S. Rehman, S. Baka, S. Lau, F. Blackhall, P. Lorigan, N. Thatcher
Concomitant CXCR4 and CXCR7 Expression Predicts Poor Prognosis in Renal Cancer
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 7 Year: 2010 Page: 772-781
Author(s): C. DAlterio, C. Consales, M. Polimeno, R. Franco, L. Cindolo, L. Portella, M. Cioffi, R. Calemma, L. Marra, L. Claudio, S. Perdona, S. Pignata, G. Facchini, G. Carteni, N. Longo, L. Pucci, A. Ottaiano, S. Costantini, G. Castello, S. Scala
Current Research Status of Microchannel Thermal Management Technology
Journal: Recent Patents on Mechanical Engineering
Volume: 8 Issue: 2 Year: 2015 Page: 120-131
Author(s): Wenchao Tian,Sanjuan Wei
Poor Response to Antiplatelet Drugs. An Important Issue in Drug-Eluting Stents.
Journal: Current Clinical Pharmacology
Volume: 8 Issue: 4 Year: 2013 Page: 340-349
Author(s): Hugo Á. del Castillo-Carnevali, Vivencio B. Alonso, José Sabán-Ruiz, José L. Z. Gómez
High CXCR4 Expression Correlates with Sunitinib Poor Response in Metastatic Renal Cancer
Journal: Current Cancer Drug Targets
Volume: 12 Issue: 6 Year: 2012 Page: 693-702
Author(s): C. D'Alterio, L. Portella, A. Ottaiano, M. Rizzo, G. Carteni, S. Pignata, G. Facchini, S. Perdona, G. Di Lorenzo, R. Autorino, R. Franco, A. La Mura, O. Nappi, G. Castello, S. Scala
ASPM Predicts Poor Clinical Outcome and Promotes Tumorigenesis for Diffuse Large B-cell Lymphoma
Journal: Current Cancer Drug Targets
Volume: 21 Issue: 1 Year: 2021 Page: 80-89
Author(s): Jingjing Wu,Zhengmei He,Yaning Zhu,Chao Jiang,Yuan Deng,Bin Wei
Pembrolizumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Analysis of Prognostic Factors of Outcomes
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 7 Year: 2022 Page: 1278-1285
Author(s): Carmelo Tibaldi,Francesca Mazzoni,Vieri Scotti,Enrico Vasile,Daniele Pozzessere,Irene Stasi,Andrea Camerini,Francesca Federici,Giulia Meoni,Chiara Caparello,Marianna Turrini,Virginia Rossi,Lucia Pia Ciccone,Irene Pecora,Beatrice Fantechi,Lorenzo Antonuzzo,Diana Giannarelli,Editta Baldini
Current Status and Future of Target-Based Therapeutics
Journal: Current Cancer Drug Targets
Volume: 7 Issue: 3 Year: 2007 Page: 273-284
Author(s): Ryoko Suzuki, Parijatha Rao, Shiro Sasaguri
Complete Response in 5 Out of 38 Patients with Advanced Hepatocellular Carcinoma Treated with Stem Cell Differentiation Stage Factors: Case Reports from a Single Centre
Journal: Current Pharmaceutical Biotechnology
Volume: 12 Issue: 2 Year: 2011 Page: 254-260
Author(s): T. Livraghi, R. Ceriani, A. Palmisano, V. Pedicini, M. G. Pich, M. A. Tommasini, G. Torzilli
A Novel Combined Model to Predict the Prognosis of COVID-19: RadiologicalmetabolicScoring
Journal: Current Medical Imaging
Volume: 20 Issue: 1 Year: 2024 Page: 1-10
Author(s): Seray Akçalar Zorlu